Department of Defense Gulf War Illness Research Program Funding Opportunities for Fiscal Year 2018 (FY18)

Posted on by

FY18 GWIRP Program Announcements and General Application Instructions for the following award mechanisms are posted on Grants.gov. 

As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency (DHA) J9, Research and Development Directorate manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation.  The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP).

The following mechanisms have been released:

http://cdmrp.army.mil/funding/gwirp

Clinical Trial Award – Preproposal due July 13, 2018

  • Independent investigators at all academic levels
  • Submission of a pre-application is required: application submission is by invitation only.
  • Supports rapid implementation of clinical trials with the potential to have a significant impact on GWI.
  • Proposed projects may range from small proof-of-concept trials through large-scale, definitive trials.
  • Early phase or pilot clinical trials (Phase 0, I, or I/II) do not require preliminary data. Larger, more definitive clinical trials, including expansion of promising pilot trials, must include preliminary data to include safety in a GWI Veteran population.

Biorepository Contribution Option:

  • Supports additional costs associated with submission of samples and data to the GWIRP supported Biorepository Resource Network.
  • Applicants must submit a Biorepository Contribution Statement providing a detailed accounting of proposed costs and a commitment to work with the GWIRP-supported Biorepository Resource Network.
  • Application to this option is not a requirement for Clinical Trial Award submission.
  • Maximum funding of $825,000 for direct costs (plus indirect costs).
  • Maximum funding of $841,000 for direct costs with the Biorepository Contribution Option (plus indirect costs).
  • Maximum period of performance is 4 years

Qualitative Research Award – Preproposal due July 13, 2018

  • Independent investigators at all academic levels
  • Submission of a pre-application is required; application submission is by invitation only.
  • Supports qualitative research studies that seek to understand the experiences, perceptions, barriers, and beliefs of Veterans suffering from GWI and those responsible for their care.
  • Research outcomes should ultimately be translated into educational materials and tools to better inform Veterans and their caregivers of healthcare providers about GWI and its care.
  • Clinical trials are not allowed.
  • Maximum funding is $400,000 for direct costs (plus indirect costs)
  • Maximum period of performance is 3 years

Investigator-Initiated Focused Research Award – Preproposal due July 13, 2018

  • Independent investigators at all academic levels
  • Submission of pre-application is required; application submission is by invitation only.
  • Supports research from idea generation through preclinical validation under two tiers:
    • Discovery Tier: Supports basic research and proof-of-concept research; preliminary data are not required.
    • Applied Research Tier: Supports advanced development of more mature therapeutic or diagnostic research. Projects may range from target or marker validation to data collection for FDA submission.  Preliminary data from the field of GWI are required.
  • Clinical trials are not allowed

Biorepository Contribution Option:

  • Supports additional costs associated with submission of samples and data to the GWIRP-supported Biorepository Resource Network.
  • Applicants must submit a Biorepository Contribution Statement providing a detailed accounting of proposed costs and a commitment to work with the GWIRP-supported Biorepository Resource Network.
  • Application to this option is not a requirement for Clinical Trial Award Submission
  • Maximum direct costs and period of performance vary based on Tier:
    • Discovery Tier: Maximum funding of $230,000 or $246,000 with the Biorepository Contribution Option for direct costs (plus indirect costs) for a maximum of 2 years.
    • Applied Research Tier: Maximum funding of $700,000 or $716,000 with the Biorepository Contribution Option for direct costs (plus indirect costs) for a maximum of 3 years.

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline.  All applications must conform to the final Program Announcements and General Application Instructions that are available for electronic downloading from the Grants.gov website.  The application package containing the required forms for each award mechanism will also be found on Grants.gov.  A listing of all CDMRP funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

Applications must be submitted through the federal government’s single-entry portal, Grants.gov.  For email notification when Program Announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org.  For more information about the GWIRP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).

Point of Contact:

CDMRP Help Desk
301-682-5507
help@eBrap.org